{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:23:34Z","timestamp":1759047814010},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T00:00:00Z","timestamp":1478649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Virol."],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1002\/jmv.24717","type":"journal-article","created":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T21:42:52Z","timestamp":1477086172000},"page":"759-766","source":"Crossref","is-referenced-by-count":12,"title":["Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A\/California\/07\/09(H1N1) in murine model"],"prefix":"10.1002","volume":"89","author":[{"given":"\u0415lena S.","family":"Don","sequence":"first","affiliation":[{"name":"The Institute of General Pathology and Pathophysiology; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra G.","family":"Emelyanova","sequence":"additional","affiliation":[{"name":"The Institute of General Pathology and Pathophysiology; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia N.","family":"Yakovleva","sequence":"additional","affiliation":[{"name":"OOO \u201cNPF \u201cMATERIA MEDICA HOLDING\u201d; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nataliia V.","family":"Petrova","sequence":"additional","affiliation":[{"name":"The Institute of General Pathology and Pathophysiology; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina V.","family":"Nikiforova","sequence":"additional","affiliation":[{"name":"OOO \u201cNPF \u201cMATERIA MEDICA HOLDING\u201d; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgeniy A.","family":"Gorbunov","sequence":"additional","affiliation":[{"name":"OOO \u201cNPF \u201cMATERIA MEDICA HOLDING\u201d; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey \u0410.","family":"Tarasov","sequence":"additional","affiliation":[{"name":"OOO \u201cNPF \u201cMATERIA MEDICA HOLDING\u201d; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey G.","family":"Morozov","sequence":"additional","affiliation":[{"name":"The Institute of General Pathology and Pathophysiology; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u041eleg I.","family":"Epstein","sequence":"additional","affiliation":[{"name":"The Institute of General Pathology and Pathophysiology; Moscow Russian Federation"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"key":"10.1002\/jmv.24717-BIB0001|jmv24717-cit-0001","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/vim.2006.19.147","article-title":"Cellular immunity and lung injury in respiratory virus infection","volume":"19","author":"Bruder","year":"2006","journal-title":"Viral Immunol"},{"key":"10.1002\/jmv.24717-BIB0002|jmv24717-cit-0002","doi-asserted-by":"crossref","first-page":"19.11.1","DOI":"10.1002\/0471142735.im1911s42","article-title":"Influenza virus","volume":"42","author":"Cottey","year":"2001","journal-title":"Curr Protoc Immunol"},{"key":"10.1002\/jmv.24717-BIB0003|jmv24717-cit-0003","doi-asserted-by":"crossref","first-page":"e0119115","DOI":"10.1371\/journal.pone.0119115","article-title":"Adamantane-resistant influenza A viruses in the world (1902-2013): Frequency and distribution of M2 gene mutations","volume":"10","author":"Dong","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1002\/jmv.24717-BIB0004|jmv24717-cit-0004","first-page":"336","volume-title":"Ultralow doses (history of one research)","author":"Epstein","year":"2009"},{"key":"10.1002\/jmv.24717-BIB0005|jmv24717-cit-0005","first-page":"54","article-title":"The phenomenon of release activity and the hypothesis of \u201cspatial\u201d homeostasis","volume":"44","author":"Epstein","year":"2013","journal-title":"Usp Fiziol Nauk"},{"key":"10.1002\/jmv.24717-BIB0006|jmv24717-cit-0006","first-page":"62","article-title":"Application of drugs based on release-active antibodies as immunotherapy agents","volume":"5","author":"Gavrilova","year":"2014a","journal-title":"J Clin Cell Immunol"},{"key":"10.1002\/jmv.24717-BIB0007|jmv24717-cit-0007","doi-asserted-by":"crossref","first-page":"e97017","DOI":"10.1371\/journal.pone.0097017","article-title":"Novel approach to activity evaluation for release-active forms of anti-interferon-gamma antibodies based on enzyme-linked immunoassay","volume":"9","author":"Gavrilova","year":"2014b","journal-title":"PLoS ONE"},{"key":"10.1002\/jmv.24717-BIB0008|jmv24717-cit-0008","first-page":"107","article-title":"Modern approaches for the investigation of natural autoantibodies to cytokine by various immunoassays","volume":"35","author":"Gavrilova","year":"2014","journal-title":"Immunologiya"},{"key":"10.1002\/jmv.24717-BIB0009|jmv24717-cit-0009","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2147\/NDT.S92456","article-title":"In vitro screening of major neurotransmitter systems possibly involved in the mechanism of action of antibodies to S100 protein in released-active form","volume":"11","author":"Gorbunov","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1002\/jmv.24717-BIB0010|jmv24717-cit-0010","unstructured":"1996 7th edition Washington D.C National Academy Press 125"},{"key":"10.1002\/jmv.24717-BIB0011|jmv24717-cit-0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08","volume":"15","author":"Hauge","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1002\/jmv.24717-BIB0012|jmv24717-cit-0012","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","article-title":"The epidemiology and spread of drug resistant human influenza viruses","volume":"8","author":"Hurt","year":"2014","journal-title":"Curr Opin Virol"},{"key":"10.1002\/jmv.24717-BIB0013|jmv24717-cit-0013","first-page":"15","volume-title":"Guideline for industry. Dose-response information to support drug registration","year":"1994"},{"key":"10.1002\/jmv.24717-BIB0014|jmv24717-cit-0014","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.4049\/jimmunol.0803743","article-title":"Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway","volume":"182","author":"Khoufache","year":"2009","journal-title":"J Immunol"},{"key":"10.1002\/jmv.24717-BIB0015|jmv24717-cit-0015","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1002\/jmv.24717-BIB0016|jmv24717-cit-0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virusres.2015.02.003","article-title":"Influenza virus activation of the interferon system","volume":"209","author":"Killip","year":"2015","journal-title":"Virus Res"},{"key":"10.1002\/jmv.24717-BIB0017|jmv24717-cit-0017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.micpath.2015.09.002","article-title":"Novel reassortant influenza viruses between pandemic (H1N1) 2009 and other influenza viruses pose a risk to public health","volume":"89","author":"Kong","year":"2015","journal-title":"Microb Pathog"},{"key":"10.1002\/jmv.24717-BIB0018|jmv24717-cit-0018","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","article-title":"Advances in the development of influenza virus vaccines","volume":"14","author":"Krammer","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/jmv.24717-BIB0019|jmv24717-cit-0019","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10517-009-0703-z","article-title":"Anaferon (pediatric formulation) in prophylactics of acute respiratory viral infection in children","volume":"148","author":"Kudin","year":"2009","journal-title":"Bull Exp Biol Med"},{"key":"10.1002\/jmv.24717-BIB0020|jmv24717-cit-0020","volume-title":"Reference Module in Biomedical Research","author":"Lamb","year":"2014"},{"key":"10.1002\/jmv.24717-BIB0021|jmv24717-cit-0021","first-page":"125","article-title":"A novel antiviral based on oral antibodies: Clinical benefits in paediatric upper respiratory infections","volume":"10","author":"Martyushev-Poklad","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/jmv.24717-BIB0022|jmv24717-cit-0022","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2174\/138955751410141020150822","article-title":"Viral M2 ion channel protein: A promising target for anti-influenza drug discovery","volume":"14","author":"Moorthy","year":"2014","journal-title":"Mini Rev Med Chem"},{"key":"10.1002\/jmv.24717-BIB0023|jmv24717-cit-0023","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.micinf.2008.09.013","article-title":"Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: Insights into viral virulence, tissue tropism and host pathogenesis","volume":"11","author":"Narasaraju","year":"2009","journal-title":"Microbes Infect"},{"key":"10.1002\/jmv.24717-BIB0024|jmv24717-cit-0024","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cmi.2014.11.020","article-title":"Neuraminidase inhibitors: Who, when, where","volume":"21","author":"Nguyen-Van-Tam","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/jmv.24717-BIB0025|jmv24717-cit-0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10517-009-0702-0","article-title":"Interferon status in children during acute respiratory infections. Therapy with interferon","volume":"148","author":"Obraztsova","year":"2009","journal-title":"Bull Exp Biol Med"},{"key":"10.1002\/jmv.24717-BIB0026|jmv24717-cit-0026","first-page":"430629","article-title":"A review of the antiviral susceptibility of human and avian influenza viruses over the last decade","volume":"2014","author":"Oh","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"10.1002\/jmv.24717-BIB0027|jmv24717-cit-0027","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-0036-1584801","article-title":"Human influenza virus infections","volume":"37","author":"Peteranderl","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1002\/jmv.24717-BIB0028|jmv24717-cit-0028","doi-asserted-by":"crossref","first-page":"12510","DOI":"10.1128\/JVI.01776-13","article-title":"Gamma interferon regulates contraction of the influenza virus-specific CD8 T cell response and limits the size of the memory population","volume":"87","author":"Prabhu","year":"2013","journal-title":"J Virol"},{"key":"10.1002\/jmv.24717-BIB0029|jmv24717-cit-0029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.intimp.2014.04.029","article-title":"Application of a heterogeneous immunoassay for the quality control testing of release-active forms of diclofenac","volume":"21","author":"Pschenitza","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1002\/jmv.24717-BIB0030|jmv24717-cit-0030","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1002\/jmv.24717-BIB0031|jmv24717-cit-0031","volume-title":"Merck Manual. Vol. 2015","author":"Reeves","year":"2015"},{"key":"10.1002\/jmv.24717-BIB0032|jmv24717-cit-0032","first-page":"7","article-title":"Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: Experimental study of influenza infection in mice","volume":"49","author":"Sergeev","year":"2004","journal-title":"Antibiot Khimioter"},{"key":"10.1002\/jmv.24717-BIB0033|jmv24717-cit-0033","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-8674(02)00639-6","article-title":"Origins of human virus diversity","volume":"108","author":"Sharp","year":"2002","journal-title":"Cell"},{"key":"10.1002\/jmv.24717-BIB0034|jmv24717-cit-0034","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1023\/A:1024734930896","article-title":"Immunotropic effects of potentiated antibodies to human interferon-gamma","volume":"135","author":"Sherstoboev","year":"2003","journal-title":"Bull Exp Biol Med"},{"key":"10.1002\/jmv.24717-BIB0035|jmv24717-cit-0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10517-009-0378-5","article-title":"Study of efficiency of therapeutic and preventive anaferon (pediatric formulation) in mice with influenza infection","volume":"146","author":"Shishkina","year":"2008","journal-title":"Bull Exp Biol Med"},{"key":"10.1002\/jmv.24717-BIB0036|jmv24717-cit-0036","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s10517-010-1006-0","article-title":"Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1\/09)","volume":"149","author":"Shishkina","year":"2010","journal-title":"Bull Exp Biol Med"},{"key":"10.1002\/jmv.24717-BIB0037|jmv24717-cit-0037","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ddmod.2004.01.003","article-title":"Experimental disease models of influenza virus infections: Recent developments","volume":"1","author":"Sidwell","year":"2004","journal-title":"Drug Discov Today Dis Models"},{"key":"10.1002\/jmv.24717-BIB0038|jmv24717-cit-0038","first-page":"3","article-title":"Efficacy of therapeutic and prophylactic actions of ultralow doses of antibodies to gamma-interferon in experimental murine model of herpes virus","volume":"49","author":"Susloparov","year":"2004","journal-title":"Antibiot Khimioter"},{"key":"10.1002\/jmv.24717-BIB0039|jmv24717-cit-0039","first-page":"37","volume-title":"5th Congress of European Pharmacology Society. Vol. 22","author":"Tarasov","year":"2008"},{"key":"10.1002\/jmv.24717-BIB0040|jmv24717-cit-0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.antiviral.2011.11.018","article-title":"Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice","volume":"93","author":"Tarasov","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1002\/jmv.24717-BIB0041|jmv24717-cit-0041","first-page":"32","article-title":"Use of ultralow doses of antibodies to gamma-interferon in the treatment and prophylaxis of viral infections","volume":"53","author":"Vasil'ev","year":"2008","journal-title":"Antibiot Khimioter"},{"key":"10.1002\/jmv.24717-BIB0042|jmv24717-cit-0042","unstructured":"Waynforth DHB Brain PP Sharpe MT Stewart MDF Applebee MKA Darke DPGG 1998"},{"key":"10.1002\/jmv.24717-BIB0043|jmv24717-cit-0043","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9440(10)63950-8","article-title":"Production of interferon-gamma by influenza hemagglutinin-specific CD8 effector T cells influences the development of pulmonary immunopathology","volume":"158","author":"Wiley","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1002\/jmv.24717-BIB0044|jmv24717-cit-0044","first-page":"17","article-title":"Immunotropic properties of anaferon and anaferon pediatric","volume":"58","author":"Zhavbert","year":"2013","journal-title":"Antibiot Khimioter"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24717","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24717","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jmv.24717\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T23:48:35Z","timestamp":1657496915000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24717"}},"subtitle":["Dose-Related Antiviral Activity of RAF Ab to IFN"],"short-title":[],"issued":{"date-parts":[[2016,11,9]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"URL":"https:\/\/doi.org\/10.1002\/jmv.24717","archive":["Portico"],"relation":{},"ISSN":["0146-6615"],"issn-type":[{"value":"0146-6615","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,9]]}}}